Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 17-May-13 7:25 PM View:  | Moy Jeffrey SVP, Operations | DexCom, Inc. (DXCM) | 15-May-13 | Option Exercise | 5,000 | $3.19 | $15,950.00 | 3% 194.25K to 199.25K | |
| 17-May-13 7:25 PM View: | Moy Jeffrey SVP, Operations | DexCom, Inc. (DXCM) | 15-May-13 | Market Option Sale | 5,000 | $19.97 | $99,872.50 | (3%) 199.25K to 194.25K | 3% |
| 13-May-13 6:58 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 13-May-13 | Market Option Sale | 45,000 | $19.40 | $873,000.00 | (24%) 189.57K to 144.57K | (2%) |
| 13-May-13 6:58 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 13-May-13 | Option Exercise | 45,000 | $2.40 | $108,000.00 | 31% 144.57K to 189.57K | |
| 13-May-13 6:59 PM View: | Doubleday Richard SVP, Worldwide Sales | DexCom, Inc. (DXCM) | 09-May-13 | Market Sale | 1,272 | $19.56 | $24,875.20 | (1%) 93.25K to 91.97K | (1%) |
| 01-May-13 7:43 PM View: | Gregg Terrance H CEO Director | DexCom, Inc. (DXCM) | 01-May-13 | Market Sale (Planned) | 9,000 | $16.84 | $151,596.00 | (< 1%) 1.04M to 1.03M | 3% |
| 03-Apr-13 7:32 PM View: | Gregg Terrance H CEO Director | DexCom, Inc. (DXCM) | 01-Apr-13 | Market Sale (Planned) | 9,000 | $16.90 | $152,118.00 | (< 1%) 1.05M to 1.04M | (2%) |
| 13-Mar-13 7:26 PM View: | Moy Jeffrey SVP, Operations | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 10,423 | $15.69 | $163,537.00 | (5%) 204.67K to 194.25K | (7%) |
| 13-Mar-13 7:36 PM View: | Roper Jess VP, CFO | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 5,001 | $15.69 | $78,465.70 | (6%) 86.65K to 81.65K | (7%) |
| 13-Mar-13 8:55 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 21,395 | $15.69 | $335,688.00 | (9%) 237.67K to 216.28K | (7%) |
| 13-Mar-13 7:15 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 13-Mar-13 | Market Option Sale | 15,416 | $16.53 | $254,814.00 | (10%) 159.99K to 144.57K | (3%) |
| 13-Mar-13 8:43 PM View: | Sayer Kevin R President & COO Director | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 15,901 | $15.69 | $249,487.00 | (4%) 374.27K to 358.37K | (7%) |
| 15-Mar-13 5:53 PM View: | Valdes Jorge A CTO | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 15,655 | $15.69 | $245,627.00 | (8%) 200.89K to 185.24K | (7%) |
| 13-Mar-13 8:31 PM View: | Lister John VP of Legal Affairs | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 5,947 | $15.69 | $93,308.40 | (7%) 85.71K to 79.76K | (7%) |
| 13-Mar-13 7:15 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 9,647 | $15.69 | $151,361.00 | (6%) 169.63K to 159.99K | (8%) |
| 13-Mar-13 7:20 PM View: | Doubleday Richard SVP, Worldwide Sales | DexCom, Inc. (DXCM) | 13-Mar-13 | Disposition | 4,067 | $15.69 | $63,811.20 | (4%) 97.31K to 93.25K | (7%) |
| 13-Mar-13 7:15 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 13-Mar-13 | Option Exercise | 15,416 | $0.50 | $7,708.00 | 10% 154.22K to 169.63K | |
| 12-Mar-13 7:42 PM View: | Valdes Jorge A CTO | DexCom, Inc. (DXCM) | 12-Mar-13 | Market Sale | 21,054 | $16.31 | $343,424.00 | (9%) 221.94K to 200.89K | 5% |
| 12-Mar-13 7:42 PM View: | Valdes Jorge A CTO | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 71,621 | $0.00 | $71.62 | 47% 152.32K to 223.94K | |
| 12-Mar-13 7:42 PM View: | Valdes Jorge A CTO | DexCom, Inc. (DXCM) | 11-Mar-13 | Market Sale | 2,000 | $15.58 | $31,162.00 | (< 1%) 223.94K to 221.94K | < 1% |
| 13-Mar-13 8:31 PM View: | Lister John VP of Legal Affairs | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 35,000 | $0.00 | $35.00 | 63% 55.21K to 90.21K | |
| 13-Mar-13 7:15 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 50,000 | $0.00 | $50.00 | 48% 104.22K to 154.22K | |
| 13-Mar-13 7:20 PM View: | Doubleday Richard SVP, Worldwide Sales | DexCom, Inc. (DXCM) | 11-Mar-13 | Market Sale | 5,100 | $15.63 | $79,699.20 | (5%) 102.41K to 97.31K | (7%) |
| 11-Mar-13 7:29 PM View: | Skyler Jay S Director | DexCom, Inc. (DXCM) | 11-Mar-13 | Market Purchase | 70,000 | $15.50 | $1,085,000.00 | 34% 204.04K to 274.04K | 3% |
| 13-Mar-13 6:20 PM View: | Gregg Terrance H CEO Director | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 182,813 | $0.00 | $182.81 | 21% 865.35K to 1.05M | |
| 13-Mar-13 7:20 PM View: | Doubleday Richard SVP, Worldwide Sales | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 50,000 | $0.00 | $50.00 | 95% 52.41K to 102.41K | |
| 13-Mar-13 7:26 PM View: | Moy Jeffrey SVP, Operations | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 50,000 | $0.00 | $50.00 | 32% 154.67K to 204.67K | |
| 13-Mar-13 7:36 PM View: | Roper Jess VP, CFO | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 30,000 | $0.00 | $30.00 | 53% 56.65K to 86.65K | |
| 13-Mar-13 8:55 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 71,621 | $0.00 | $71.62 | 43% 166.05K to 237.67K | |
| 13-Mar-13 8:31 PM View: | Lister John VP of Legal Affairs | DexCom, Inc. (DXCM) | 11-Mar-13 | Market Sale | 4,500 | $15.75 | $70,875.00 | (5%) 90.21K to 85.71K | (6%) |
| 13-Mar-13 8:43 PM View: | Sayer Kevin R President & COO Director | DexCom, Inc. (DXCM) | 11-Mar-13 | Grant | 150,000 | $0.00 | $150.00 | 67% 224.27K to 374.27K | |
| 12-Mar-13 7:42 PM View: | Valdes Jorge A CTO | DexCom, Inc. (DXCM) | 08-Mar-13 | Market Sale | 1,000 | $15.61 | $15,610.00 | (< 1%) 153.32K to 152.32K | < 1% |
| 05-Mar-13 4:46 PM View: | Gregg Terrance H CEO Director | DexCom, Inc. (DXCM) | 01-Mar-13 | Market Sale (Planned) | 9,000 | $14.76 | $132,858.00 | (1%) 874.35K to 865.35K | (4%) |
| 28-Feb-13 7:06 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 28-Feb-13 | Option Exercise | 25,000 | $3.19 | $79,750.00 | 15% 166.05K to 191.05K | |
| 28-Feb-13 7:06 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 28-Feb-13 | Market Option Sale | 25,000 | $14.99 | $374,850.00 | (13%) 191.05K to 166.05K | (1%) |
| 28-Feb-13 7:06 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 27-Feb-13 | Option Exercise | 20,000 | $3.19 | $63,800.00 | 12% 166.05K to 186.05K | |
| 28-Feb-13 7:06 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 27-Feb-13 | Market Option Sale | 20,000 | $15.01 | $300,100.00 | (11%) 186.05K to 166.05K | (1%) |
| 28-Feb-13 7:06 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 26-Feb-13 | Option Exercise | 30,000 | $3.19 | $95,700.00 | 18% 166.05K to 196.05K | |
| 28-Feb-13 7:06 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 26-Feb-13 | Market Option Sale | 30,000 | $14.94 | $448,350.00 | (15%) 196.05K to 166.05K | (2%) |
| 05-Feb-13 5:38 PM View: | Gregg Terrance H CEO Director | DexCom, Inc. (DXCM) | 01-Feb-13 | Market Sale (Planned) | 9,000 | $15.08 | $135,702.00 | (1%) 883.35K to 874.35K | (< 1%) |
| 04-Jan-13 4:49 PM View: | Gregg Terrance H CEO Director | DexCom, Inc. (DXCM) | 02-Jan-13 | Market Sale (Planned) | 9,000 | $13.89 | $125,010.00 | (1%) 892.35K to 883.35K | (10%) |
| 18-Dec-12 6:53 PM View: | Gregg Terrance H CEO Director | DexCom, Inc. (DXCM) | 14-Dec-12 | Gift | 75,000 | -- | -- | (8%) 967.35K to 892.35K | |
| 14-Dec-12 5:40 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 13-Dec-12 | Market Sale | 5,760 | $13.98 | $80,527.70 | (5%) 116.73K to 110.97K | (9%) |
| 14-Dec-12 5:39 PM View: | Valdes Jorge A CTO | DexCom, Inc. (DXCM) | 13-Dec-12 | Market Sale | 27,750 | $14.02 | $388,981.00 | (15%) 181.07K to 153.32K | (9%) |
| 14-Dec-12 5:40 PM View: | Balo Andrew K SVP, Regulatory and Clinical | DexCom, Inc. (DXCM) | 13-Dec-12 | Market Sale | 7,000 | $13.96 | $97,696.90 | (6%) 110.97K to 103.97K | (9%) |
| 14-Dec-12 5:39 PM View: | Valdes Jorge A CTO | DexCom, Inc. (DXCM) | 12-Dec-12 | Market Sale | 4,122 | $14.29 | $58,912.90 | (2%) 185.19K to 181.07K | (6%) |
| 12-Dec-12 7:47 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 11-Dec-12 | Option Exercise | 10,000 | $3.19 | $31,900.00 | 6% 166.05K to 176.05K | |
| 12-Dec-12 7:47 PM View: | Pacelli Steven Robert EVP, Strategy & Corp. Dev. | DexCom, Inc. (DXCM) | 11-Dec-12 | Market Option Sale | 10,000 | $14.26 | $142,645.00 | (6%) 176.05K to 166.05K | (7%) |
| 12-Dec-12 8:03 PM View: | Roper Jess VP, CFO | DexCom, Inc. (DXCM) | 10-Dec-12 | Market Sale | 3,715 | $13.84 | $51,418.50 | (6%) 64.43K to 60.72K | (10%) |
| 12-Dec-12 8:03 PM View: | Roper Jess VP, CFO | DexCom, Inc. (DXCM) | 10-Dec-12 | Market Sale | 5,000 | $13.85 | $69,250.00 | (8%) 60.72K to 55.72K | (10%) |
